Prophylaxis of herpetic infections reactivation before the planned pregnancy
DOI:
https://doi.org/10.14739/2310-1210.2018.4.135804Keywords:
cytomegalovirus infections, herpes labialis, genital herpesAbstract
The aim of the work – to estimate serum and molecular-genetic markers of chronic CMV-, HSV1- and HSV2-infection reactivation, that can result in the prenatal pathology, and also to offer the effective medicamentous prophylaxis of these herpetic infections at the stage of pregnancy planning.
Materials and methods. 42 women with serum and/or molecular-genetic markers of chronic herpetic infections reactivation and a high risk of fetus damage were examined at the stage of repeated pregnancy planning.
Results. Significance of clinical and laboratory signs of chronic herpetic infection reactivation has been estimated. Repeated detection of IgM to СMV in blood can be interpreted as a sign of chronic CMV-infection exacerbation. However, an absolute value has СMV genetic material detection in blood (PCR method), but not in saliva. Repeated seroconversion of IgA and IgM to HSV1/2 and also НSV1 DNA in blood or НSV2 DNA in urogenital mucus detection can be interpreted in the same manner. High level of IgG to СMV, HSV1 and HSV2 do not indicate the corresponding chronic herpetic infection reactivation. Avidity of аnti-CMV IgG, аnti-НSV2 IgG at chronic herpetic infections also is always high. An increase in IgG corresponding levels in 4 times and more in pared serum samples does not occur in the case of herpetic infection reactivation. Complex prevention of congenital herpetic infections targeting women from the risk group should be taken at the stage of pregnancy planning by adding a cytokine-like preparation “Allokin-alpha” to the etiotropic therapy. In contrast to basic treatment only, such combination allows to avoid herpetic infections reactivation (СMV, HSV1 and HSV2) during pregnancy in 100 % of cases.
Conclusions. For detection of СMV reactivation the focus should be primarily on the clinical and other laboratory signs of CMV-infection: temperature rise, liver enlargement, leukocytosis and monocytosis, increase in lymphoblasts number, increase in activity of alanin-, aspartataminotranspherase and γ-glutamiltranspeptidase. As distinct from infectious mononucleosis, there are no lymphadenopathy and tonsillitis. Typical lip or perioral vesicular exanthema, aphthae on the mucous membrane of oral cavity and so on (orofacial herpes), vesicular rash on the mucous membrane of vulva, vagina, and cervix uteri (genital herpes) with a local itch, tenderness, burning sensation and general intoxication manifestations are of key importance clinical sings for reactivation of chronic НSV infection diagnostics. Titer of IgG to СMV, HSV1 and HSV2, increase in their level in pared serum samples and also their avidity in chronic herpetic infections are no reliable criteria for reactivation. The women from the risk group at the stage of pregnancy planning are advised to prevent the congenital herpetic infection by means of complex valaciclovir intake 0.5 g 2 times daily for 7–10 days and 6 hypodermic injections of “Allokin-alpha” in a dose of 1 mg on alternate day.
References
Kramarev, S. O. (2007) Problemni pytannіa infektsiinykh khvorob v Ukraini [Problematic Issues of Infectious Diseases in Ukraine]. Zdorovia Ukrainy, 2/1, 7–8. [in Ukrainian].
Aleksandrin, A. V., & Kolesnikova, I. P. (2010) Stan protykrasnushnoho imunitetu u vahitnykh i zhinok ditorodnoho viku [Condition of anti-redness immunity in pregnant women and women of childbearing age]. Simeina medytsyna, 2, 36–38 [in Ukrainian].
Hryhorovych, L. V. (2006) Vplyv na vnutrishnioutrobnyі plid virusnoi ta parvovirusnoi infektsii [Effect on the Fetal Fruit of the Viral and Parvovirus Infection]. Zhurnal praktychnoho likaria, 3, 34–38 [in Ukrainian].
Turianytsya, S. M., Korchynska, O. O., & Dankanych, Ye. E. (2013) TORCH-infektsii ta vahitnist [TORCH Infection and Pregnancy]. Medprosvita. Retrieved from: https://medprosvita.com.ua/torch-infekciyi-ta-vagitnist. [in Ukrainian].
Guerreiro, M., Na, I. K., Letsch, A., Haase, D., Bauer, S., Meisel, C., et al. (2010) Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. Eur. J. Immunol, 40(6), 1566–76. doi: 10.1002/eji.200940000.
lZhilyaev, N. I., Vasil'eva, N. A., Zhilyaev, N. N., Savula, M. M., Malanchuk, L. M., & Kutsenko, A. V. (2011) Perinatal'nye infekcii [Perinatal infections]. Ternopil: Pidruchnyky i posibnyky. [in Russian].
Martinez, A. S., Martinez, L. A., Teatino, P. M., & Rodriguez-Grander, J. (2011) Diagnosis of congenital infection. Enferm. Infec. Microbiol. Clin., 5, 15–20. doi: 10.1016/S0213-005X(11)70039-8.
Cunningham, A. L., Diefenbach, R. J., Miranda-Saksena, M., Bosnjak, L., Kim, M., Jones, C., & Douglas, M. W. (2006) The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis., 15, 194(1), S11-8.
Chernysh, S., Kim, S. I., Bekker, G., Pleskach, V. A., Filatova, N. A., Anikin, V. B., Platonov, V. G., & Bulet, P. (2002) Antiviral and antitumor peptides from insects. Proc. Nat. Acad. Sci. USA, 1, 99(20), 12628–32. doi: 10.1073/pnas.192301899.
Duda, A. K., Kotsiubailo, L. P., & Okruzhnov, N. V. (2014) Primenenie protivovirusnogo preparata novogo pokoleniya Allokin-alfa v terapii social'no znachimykh virusnykh infekcij [Using antiviral drug of new generation, allokin alfa, in the therapy for socially significant viral infections]. Aktualna ínfektolohiia, 4(5), 16–24. [in Russian].
Sokolenko, M. O. (2015) Vdoskonalennia likuvannia khvorykh na VIL-asotsiiovanu herpetychnu infektsiiu [Improve treatment for hivassociated herpes infection]. Infektsiini khvoroby, 3(81), 20–27 [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
